---
title: >-
  Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early
  Antiretroviral Treatment in the Botswana Combination Prevention Project.
description: >-
  Explore this publication on real-world evidence: Health Impact and
  Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment
  in the…
date: '2022-01-01'
category: Publications
tags:
  - Journal Of Acquired Immune Deficiency Syndromes
  - Oral Presentation
  - R&D
  - Care
  - Methods/Pharmacoepi
  - HIV
  - Health System Partner
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/journal-of-acquired-immune-deficiency-syndromes/health-impact-and-cost-effectiveness-of-hiv-testing-linkage/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: health-impact-and-cost-effectiveness-of-hiv-testing-linkage
id: 5EfkUziNDjpQpv2ErXoO7q
contentType: article
---

## Challenge

The health impact and cost-effectiveness of the BCPP combination prevention strategy had not been projected over a lifetime horizon using formal health economic modeling, limiting the evidence base for scaling similar interventions.

## Solution

Harvard and CDC researchers used the CEPAC model to project the lifetime health impact and cost-effectiveness of BCPP combination prevention versus standard of care, using trial data on ART initiations and infections averted.

## Impact

Demonstrating that BCPP combination prevention is cost-effective at $79 per QALY provides policymakers and global health funders with compelling economic evidence for investing in universal test-and-treat HIV prevention strategies.